Controlling liposome blood clearance by surface-grafted polymers

被引:197
作者
Woodle, MC [1 ]
机构
[1] Genet Therapy Inc, Gaithersburg, MD 20878 USA
关键词
biodistribution; liposome; pharmacokinetics; polyethylene glycol (PEG); polymer brush; targeting;
D O I
10.1016/S0169-409X(97)00136-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incorporation of polymer-lipid conjugates, initially using PEG and subsequently other selected flexible, hydrophilic polymers, into lipid bilayers gives rise to sterically stabilized liposomes that exhibit reduced blood clearance and concomitant changes in tissue distribution largely because of reduced, but not eliminated, phagocytic uptake. Changes in tissue distribution includes 'passive' targeting localization into sites of tumors, infection, inflammation characterized by presence of a 'leaky' vasculature which represent useful applications for drug delivery. The polymer forms a surface coating which has been characterized by physical measurements and it appears to function through steric inhibition of the protein binding and cellular interactions leading to phagocytic uptake. The current understanding of the physical and biological properties are reviewed. Ongoing work in the field involves interests to increase complexity such as addition of (1) selective targeting ligands by chemical conjugation to the exterior surface of the polymer coating, (2) capabilities for intracellular release of encapsulated agents into the cytoplasm, and (3) both simultaneously. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 129 条
  • [1] AHMAD I, 1993, CANCER RES, V53, P1484
  • [2] Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
  • [3] THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM
    ALLEN, TM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) : 285 - 309
  • [4] PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
    ALLEN, TM
    NEWMAN, MS
    WOODLE, MC
    MAYHEW, E
    USTER, PS
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (02) : 199 - 204
  • [5] ALLEN TM, 1993, LIPOSOME TECHNOLOGY, V3, P59
  • [6] Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma
    Amantea, MA
    Forrest, A
    Northfelt, DW
    Mamelok, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (03) : 301 - 311
  • [7] IN-VITRO TESTS TO PREDICT IN-VIVO PERFORMANCE OF LIPOSOMAL DOSAGE FORMS
    AMSELEM, S
    COHEN, R
    BARENHOLZ, Y
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 1993, 64 (1-3) : 219 - 237
  • [8] CONTACT-DEPENDENT, IMMUNECOMPLEX-MEDIATED LYSIS OF HAPTEN-SENSITIZED LIPOSOMES
    BABBITT, B
    BURTIS, L
    DENTINGER, P
    CONSTANTINIDES, P
    HILLIS, L
    MCGIRL, B
    HUANG, L
    [J]. BIOCONJUGATE CHEMISTRY, 1993, 4 (03) : 199 - 205
  • [9] Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: An alternative to cationic liposome/DNA aggregates
    Bally, MB
    Zhang, YP
    Wong, FMP
    Kong, S
    Wasan, E
    Reimer, DL
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 24 (2-3) : 275 - 290
  • [10] SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES
    BLUME, G
    CEVC, G
    CROMMELIN, MDJA
    BAKKERWOUDENBERG, IAJM
    KLUFT, C
    STORM, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (01) : 180 - 184